Sero-prevalence of Hepatitis B virus infection and associated factors among pregnant women attending antenatal care service in health institutions in Gedeo Zone, Southern Ethiopia

Background: Hepatitis B virus infection is a major public health problem worldwide and is a major cause of morbidity and mortality. This study aimed to assess the prevalence of hepatitis B virus infection and associated factors among pregnant mothers in the Gedeo Zone, southern Ethiopia.Methods: An institution-based cross-sectional study was conducted in governmental and private health facilities in the Gedeo zone from January to April 2019. The study participants were selected using systematic random sampling techniques. The Eugene strip test was used to determine hepatitis B virus infection among pregnant mothers. The status of HIV was collected from the records. Other variables were collected from the mothers using interviewer-administered questionnaires. Binary logistic regression was used for the analysis. Adjusted odds ratios and their 95% confidence intervals (CIs) were calculated to determine the association between HBsAg seropositivity and various factors. A p-value of less than 0.05 was considered significant.Results: The prevalence of hepatitis B virus infection among pregnant mothers was 9.2% in the Gedeo Zone. Previous history of blood transfusion [AOR=5.2, 95% CI: 2.1, 12.5], previous history of hospital admission [AOR=3, 95% CI: 1.4, 6.6], history of having an abortion [AOR=4.1, 95% CI: 1.5, 11.7], age of the pregnant women [AOR=5.1, 95% CI: 1.5, 18.0], and HIV status of the mother [AOR=8.1, 95% CI: 1.9, 36.0] had a statistically significant association with HBsAg seropositivity.Conclusions: Hepatitis B virus infection was found to have higher endemicity (9.2%) in the Gedeo Zone which is higher than the national pooled prevalence which was 4.75%. Early initiation of antenatal care services which incorporate the prevention and control of HBV must be implemented by the health facilities in the Gedeo Zone.

[1]  G. Kassa,et al.  Hepatitis B Virus Infection and Its Determinants among Pregnant Women in Ethiopia: A Systematic Review and Meta-Analysis , 2020, Infectious diseases in obstetrics and gynecology.

[2]  Chaltu Fikru,et al.  Sero-prevalence of hepatitis B virus and associated factors among pregnant women in Gambella hospital, South Western Ethiopia: facility based cross-sectional study , 2019, BMC Infectious Diseases.

[3]  Setegn Eshetie,et al.  Prevalence, Infectivity, and Associated Risk Factors of Hepatitis B Virus among Pregnant Women in Yirgalem Hospital, Ethiopia: Implication of Screening to Control Mother-to-Child Transmission , 2017, Journal of pregnancy.

[4]  Robel Mekonnen,et al.  Sero-Prevalence of Hepatitis B Virus and Associated Factors Among Pregnant Mothers Attending Antenatal Care in Public Health Facilities, Dire Dawa , 2018 .

[5]  Getahun Tiruye,et al.  Seroprevalence of Hepatitis B Virus Infection and Associated Factors among Pregnant Women Attended Antenatal Care Services in Harar City, Eastern Ethiopia , 2018 .

[6]  I. Ali,et al.  Seroprevalence and associated risk factors of hepatitis B virus among pregnant women in southern Ethiopia: a hospital-based cross-sectional study , 2016, Epidemiology and health.

[7]  E. Udoh,et al.  The prevalence of hepatitis B virus infection in Nigerian children prior to vaccine introduction into the National Programme on Immunization schedule , 2016, The Pan African medical journal.

[8]  E. Tsochatzis,et al.  Global Epidemiology of Hepatitis B Virus (HBV) Infection , 2015, Current Hepatology Reports.

[9]  A. Mwaka,et al.  High prevalence of hepatitis B virus infection among pregnant women attending antenatal care: a cross-sectional study in two hospitals in northern Uganda , 2014, BMJ Open.

[10]  Chao Chen,et al.  Individualized management of pregnant women with high hepatitis B virus DNA levels. , 2014, World journal of gastroenterology.

[11]  M. El-Shabrawi Prevalence of Hepatitis B Virus Infection among Egyptian Pregnant Women - A Single Center Study , 2014 .

[12]  J. Atashili,et al.  Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study , 2014, BMC Research Notes.

[13]  K. Desta,et al.  Seroprevalence and transmission of Hepatitis B virus among delivering women and their new born in selected health facilities, Addis Ababa, Ethiopia: a cross sectional study , 2014, BMC Research Notes.

[14]  R. Cheung,et al.  Global Epidemiology of Hepatitis B Virus (HBV) Infection , 2012 .

[15]  A. Okoh,et al.  Seroprevalence of hepatitis B surface antigenemia and its effects on hematological parameters in pregnant women in Osogbo, Nigeria , 2012, Virology Journal.

[16]  H. Poustchi,et al.  Hepatitis B Virus Infection during Pregnancy: Transmission and Prevention , 2011, Middle East journal of digestive diseases.

[17]  Rosanna F. Hess,et al.  Seroprevalence of hepatitis B surface antigen among pregnant women attending the Hospital for Women & Children in Koutiala, Mali. , 2011, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[18]  G. Medhin,et al.  Prevalence of Hepatitis B surface antigen (HBsAg) among visitors of Shashemene General Hospital voluntary counseling and testing center , 2011, BMC Research Notes.

[19]  Colin W Shepard,et al.  Hepatitis B virus infection: epidemiology and vaccination. , 2006, Epidemiologic reviews.

[20]  Effect of Hepatitis B Immunization in Newborn Infants of Mothers Positive for Hepatitis B Surface Antigen: Systematic Review and Meta-Analysis , 2006 .

[21]  T. Wright Introduction to Chronic Hepatitis B Infection , 2006, The American Journal of Gastroenterology.

[22]  H. Margolis,et al.  A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[23]  K. Tse,et al.  The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study. , 2005, Journal of hepatology.

[24]  S. Gebre-selassie,et al.  Seroprevalence of HBsAg and its risk factors amoung pregnant women in Jimma, Southwest Ethiopia , 2005 .

[25]  D. Nokes,et al.  Seroepidemiology of hepatitis B virus in Addis Ababa, Ethiopia: transmission patterns and vaccine control , 2003, Epidemiology and Infection.

[26]  B. Robertson,et al.  Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. , 2002, The Journal of general virology.

[27]  L. Hernández-Ruiz,et al.  Prevalence of hepatitis B virus infection and related risk factors in a rural community of Mexico. , 2001, The American journal of tropical medicine and hygiene.

[28]  Shane Marley,et al.  Control of Communicable Diseases Manual , 1997, Annals of Internal Medicine.

[29]  C. Kiire The epidemiology and prophylaxis of hepatitis B in sub-Saharan Africa: a view from tropical and subtropical Africa. , 1996, Gut.

[30]  J. Black Women's health care. , 1988, Plastic surgical nursing : official journal of the American Society of Plastic and Reconstructive Surgical Nurses.

[31]  S. Glotzer Hepatitis in pregnancy. , 1957, New York state journal of medicine.

[32]  S. Miller,et al.  Control of communicable diseases. , 1949, The Journal-lancet.